GlassScriptPhysician profile
Khalil Takla
NPI 1306916465
$3,289.42
in general payments reported to CMS, 2019-2025
8 companies · $263 in 2025
The $263 reported for 2025 was more than what 81% of Dentist providers received nationally (typical 2025 total: $70.27).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $582 · 2020: $1,140 · 2021: $11.57 · 2022: $176 · 2023: $1,103 · 2024: $14.58 · 2025: $263.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $959 · Education: $413 · Gift: $8.70.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $958.55 |
| Education | $412.50 |
| Gift | $8.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Straumann USA LLC | $1,518.40 | 2019-2022 | |
| Dentsply Sirona INC | $1,003.40 | 2023-2025 | Waveone Gold Conform Fit |
| Align Technology, INC. | $494.93 | 2019-2025 | Invisalign |
| Nobel Biocare USA | $97.17 | 2019-2023 | Nobelactive |
| Tulsa Dental Products LLC | $79.35 | 2020 | |
| Kerr Corporation | $70.02 | 2023 | Files |
| Voco America INC. | $14.58 | 2024 | Futurabond U, Admira Fusion X-Tra, Voco Profluorid Varnish |
| Gc America INC. | $11.57 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Khalil Takla listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.